Recruiting
Phase 1

M1774 & ZEN-3694

Sponsor:

National Cancer Institute (NCI)

Code:

NCT05950464

Conditions

Endometrial Carcinoma

Endometrial Clear Cell Adenocarcinoma

Endometrial Endometrioid Adenocarcinoma

Endometrial Low Grade Endometrioid Adenocarcinoma

Ovarian Clear Cell Adenocarcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BET Bromodomain Inhibitor ZEN-3694

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Electrocardiography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-09. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-10-24.